AI drug discovery gains momentum as Merck partners with Isomorphic Labs to identify potential small-molecule cancer treatments.
Natco Pharma secures VAI status from the USFDA after four observations at its Visakhapatnam finished dosage formulations manufacturing facility.
GMP rules may see targeted relaxations in India as the government considers easing manufacturing requirements for select drug categories to reduce compliance costs.
Atopic dermatitis treatment faces a setback as Celldex discontinues barzolvolimab development following disappointing Phase 2 results.
Biopharmaceutical manufacturing in India gets a boost as the Centre prepares to roll out its Rs 10,000-crore Biopharma SHAKTI scheme.
Bajaj Group is entering India's healthcare market with Rs 2,500 crore investment plan to build an integrated network of hospitals, medical centers and home-care services in Pune.
Bispecific antibodies for cancer are gaining attention as AbbVie partners with DISCO Pharmaceuticals to develop targeted solid-tumour treatments.
India's pharmaceutical manufacturing sector could face tighter regulatory requirements as the Union Health Ministry proposes stronger oversight of antimicrobial drugs.
Ayushman Bharat scheme may expand government hospital treatment packages from 23 to 112, covering common illnesses, surgeries and screening services.
AstraZeneca Pharma India is exploring new opportunities in India's cancer care landscape through a proposed collaboration with Reliance Industries subsidiary Strand Life Sciences.